Prostate Specific Antigen Kit ELISA

N° du produit ABIN996897

Détail du produit Prostate Specific Antigen Kit ELISA

Antigène: Prostate Specific Antigen (PSA)

Reactivité: Humain

Méthode de détection: Colorimetric

Type de méthode: Sandwich ELISA

Gamme de detection: 0-60 ng/mL

Seuil minimal de détection: 0 ng/mL

Application: ELISA

Fonction: The PSA Enzyme Immunoassay test kit is intended for the quantitative determination of PSA in human serum.

Type d'échantillon: Serum

Analytical Method: Quantitative

Specificité: 98.7 %

Sensibilité: 0.5 ng/mL

Information d'application

Volume d'échantillon: 25 μL

Durée du test: 1 h

Plaque: Pre-coated

Restrictions: For Research Use only

Stockage

Stock: 4 °C

Date de péremption: 12 months

Détail du antigène

Antigène: Prostate Specific Antigen (PSA)

Autre désignation: PSA (PSA Produits)

Synonymes: APS Kit ELISA, KLK2A1 Kit ELISA, PSA Kit ELISA, hK3 Kit ELISA, KLK3 Kit ELISA, Klk1c10l2 Kit ELISA, RSGK-50 Kit ELISA, RSKG-50 Kit ELISA, rGK-3 Kit ELISA, Kal-3 Kit ELISA, Kal3 Kit ELISA, Klk3 Kit ELISA, AAP-S Kit ELISA, MP100 Kit ELISA, Psa Kit ELISA, R74825 Kit ELISA, goku Kit ELISA, kallikrein related peptidase 3 Kit ELISA, kallikrein 3 Kit ELISA, kallikrein 1-related peptidase C3 Kit ELISA, kallikrein B, plasma 1 Kit ELISA, aminopeptidase puromycin sensitive Kit ELISA, KLK3 Kit ELISA, Klk1c3 Kit ELISA, Klkb1 Kit ELISA, Npepps Kit ELISA

Sujet: Human prostate-specific antigen (PSA) is a serine protease, a sigle chain glycoprotein with a molecular weight of approximately 34,000 daltons containing 7% carbohydrate by weight. PSA is immunologically specific for prostatic tissue, it is present in normal, benign hyperplastic, and malllignant prostatic tissue, in metastatic prostatic carcinoma, and also in prostatic fluid and seminal plasma. PSA is not present in any other normal tissue obtained from men, nor is it produced by cancers of the breast, lung, colon, rectum, stomach, pancreas or thyroid. Besides, it is functionally and immunologically different from prostatic acid phosphatase (PAP). Elevated serum PSA concentrations have been reported in patients with prostate cancer, benign prostatic hypertrophy, or inflammatory conditions of other adjacent genitourinary tissues, but not in apparently healthy men, men with non-prostatic carcinoma, apparently healthy women, or women with cancer. Reports have suggested that serum PSA is one of the most useful tumor markers in oncology. It may serves as an accurate marker for assessing response to treatment in patients with prostatic cancer. Therefore, measurement of serum PSA concentrations can be an important tool in monitoring patients with prostatic cancer and in determining the potential and actual effectiveness of surgery or other therapies. Recent studies also indicate that PSA measurements can enhancce early prostate cancer detection when combined with digital rectal examination (DRE).

Pathways: Système du Complément